CLINICAL_TRIALS
trial_result
· 2012-09-12
Clinical Trial Update: Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer [Phase 3]
Summary
Phase 3 trial of thalidomide for hormone-dependent prostate cancer has completed; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2012-09-12